This week, a new paper described how researchers pieced together the entire molecular structure of the protein shell of the HIV virus using GPU-based simulations. This remarkable achievement not ...

Research by a multi-institutional team, including two members from the University of Delaware, has revealed new details about the HIV virus capsid structure and how it develops. A capsid is a protein ...

The matrix shell of the HIV-1 virus may have a different shape than previously thought, and a newly proposed model has significant implications for understanding how the virus functions.

Scientists use pore-forming toxin to punch holes in the membrane of HIV virus-like particles, making the capsid accessible to external cell factors and small molecules.

For some, however, seeing the structure of HIV may be especially potent. Luke Jerram is an artist in the U.K. who makes glass sculptures of microbes.

Scientists have determined the molecular structure of HIV Pol, a protein that plays a key role in the late stages of HIV replication, or the process through which the virus propagates itself and ...

In a discovery that could spur the development of new therapies for more than 40 million HIV patients worldwide, scientists from Rutgers University and the Salk Institute determined the molecular ...

A team of scientists at the Salk Institute and Rutgers University has determined the molecular structure of HIV Pol, a protein that plays a key role in the late stages of HIV replication, the ...

According to the study, hitting HIV’s Achilles heel may require leveraging the “social network” that governs the virus’ structure.

Left: Structure of the Human Immunodeficiency Virus (HIV). Note the envelope protein that protects the virus against immunological detection and the small genome consisting of two short strands of ...

Two recent papers identify the first peptide inhibitor that binds to the structural protein of HIV-1, thereby blocking assembly of both immature and mature virus-like particles in vitro. These ...

COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Penn researcher Drew Weissman spent decades developing mRNA technology. He says it helps target the rapidly mutating human ...